Cargando…
An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
Clozapine remains as the gold standard for the management of treatment resistant schizophrenia. Nevertheless, mortality and morbidity associated with Clozapine is partly contributed by its adverse effect of constipation in view of its prominent anticholinergic properties. Despite the evidence that a...
Autores principales: | Damodaran, Ishwary, Hui, Koh Ong, Nordin, Amer Siddiq Amer, Yee, Anne, Gill, Jesjeet Singh, Francis, Benedict, Azhar, Fatin Liyana, Sulaiman, Ahmad Hatim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761681/ https://www.ncbi.nlm.nih.gov/pubmed/33287162 http://dx.doi.org/10.3390/healthcare8040533 |
Ejemplares similares
-
Religious Coping, Religiosity, Depression and Anxiety among Medical Students in a Multi-Religious Setting
por: Francis, Benedict, et al.
Publicado: (2019) -
Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013) -
Prucalopride: the evidence for its use in the treatment of chronic constipation
por: Coremans, Georges
Publicado: (2008) -
Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
por: Nuijten, Mark J. C., et al.
Publicado: (2015) -
Patient considerations in the management of chronic constipation: focus on prucalopride
por: Shin, Andrea
Publicado: (2016)